VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma
Clinical trial NCT04151615 · COMPLETED
Trial details
- NCT number
- NCT04151615
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-15
- Primary completion
- 2023-01-11
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.